| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.36e-10 | 38 | 104 | 7 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.57e-09 | 11 | 104 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.71e-09 | 14 | 104 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.62e-08 | 21 | 104 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.33e-06 | 37 | 104 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.33e-06 | 37 | 104 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.52e-06 | 38 | 104 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.02e-06 | 46 | 104 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 WRNIP1 ERVK-7 ERVK-10 REV3L ERVK-8 POLI ERVK-11 TOP3B | 9.32e-06 | 262 | 104 | 9 | GO:0140097 |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 1.13e-05 | 9 | 104 | 3 | GO:0098634 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.48e-05 | 152 | 104 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.77e-05 | 79 | 104 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TRAF5 HIVEP1 ZNF875 ENPP3 TRIM71 ERVK-7 ERVK-10 SETDB2 ERVK-8 DMD HDAC10 ERVK-11 ZMAT1 | 2.12e-04 | 891 | 104 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 2.66e-04 | 5 | 104 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 3.98e-04 | 6 | 104 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.30e-04 | 136 | 104 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.30e-04 | 136 | 104 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | laminin binding | 7.30e-04 | 34 | 104 | 3 | GO:0043236 | |
| GeneOntologyMolecularFunction | collagen binding | 8.49e-04 | 81 | 104 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.33e-03 | 231 | 104 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.71e-03 | 12 | 104 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 WRNIP1 ERVK-7 ERVK-10 REV3L ERVK-8 POLI DDX60L ERVK-11 TOP3B | 1.97e-03 | 645 | 104 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | integrin binding | 2.23e-03 | 175 | 104 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.38e-11 | 48 | 103 | 8 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.51e-09 | 13 | 103 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 ATP23 WRNIP1 RAD9B ERVK-7 ERVK-10 REV3L INTS3 RIF1 ERVK-8 POLI HDAC10 ERVK-11 TOP3B | 4.15e-06 | 648 | 103 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 1.38e-05 | 218 | 103 | 8 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 ERVK-7 ERVK-10 REV3L INTS3 RIF1 ERVK-8 HDAC10 ERVK-11 TOP3B | 1.57e-05 | 368 | 103 | 10 | GO:0006310 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 3.13e-05 | 178 | 103 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.00e-05 | 83 | 103 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 9.34e-05 | 18 | 103 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.72e-04 | 312 | 103 | 8 | GO:0006260 | |
| Domain | Med13_N | 2.73e-05 | 2 | 98 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 2.73e-05 | 2 | 98 | 2 | IPR021643 | |
| Domain | Mediator_Med13 | 2.73e-05 | 2 | 98 | 2 | IPR009401 | |
| Domain | Med13_C | 2.73e-05 | 2 | 98 | 2 | PF06333 | |
| Domain | Integrin_alpha-2 | 1.08e-04 | 18 | 98 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.08e-04 | 18 | 98 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.08e-04 | 18 | 98 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 1.08e-04 | 18 | 98 | 3 | PS00242 | |
| Domain | Int_alpha_beta-p | 1.28e-04 | 19 | 98 | 3 | IPR013519 | |
| Domain | Int_alpha | 1.28e-04 | 19 | 98 | 3 | SM00191 | |
| Domain | FG_GAP | 2.01e-04 | 22 | 98 | 3 | PS51470 | |
| Domain | VWA | 2.12e-04 | 56 | 98 | 4 | PF00092 | |
| Domain | FG-GAP | 2.62e-04 | 24 | 98 | 3 | PF01839 | |
| Domain | FG-GAP | 2.62e-04 | 24 | 98 | 3 | IPR013517 | |
| Domain | Groucho_enhance | 2.70e-04 | 5 | 98 | 2 | IPR009146 | |
| Domain | TLE_N | 2.70e-04 | 5 | 98 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 2.70e-04 | 5 | 98 | 2 | IPR005617 | |
| Domain | Integrin_dom | 2.96e-04 | 25 | 98 | 3 | IPR032695 | |
| Domain | - | 3.67e-04 | 333 | 98 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.82e-04 | 335 | 98 | 8 | IPR015943 | |
| Domain | VWFA | 9.11e-04 | 82 | 98 | 4 | PS50234 | |
| Domain | VWA | 9.97e-04 | 84 | 98 | 4 | SM00327 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.80e-05 | 74 | 68 | 5 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.80e-05 | 74 | 68 | 5 | M16376 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.88e-05 | 83 | 68 | 5 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 7.20e-05 | 90 | 68 | 5 | M835 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.77e-04 | 23 | 68 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.77e-04 | 23 | 68 | 3 | M47720 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 2.58e-04 | 26 | 68 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 2.58e-04 | 26 | 68 | 3 | M47719 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.85e-04 | 66 | 68 | 4 | M18 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 3.23e-04 | 28 | 68 | 3 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.97e-04 | 30 | 68 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 3.97e-04 | 30 | 68 | 3 | M47718 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.89e-04 | 76 | 68 | 4 | MM14867 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 6.30e-04 | 8 | 68 | 2 | M27349 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.15e-04 | 84 | 68 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.47e-04 | 85 | 68 | 4 | M16441 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE | 8.66e-04 | 39 | 68 | 3 | M26897 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE | 8.66e-04 | 39 | 68 | 3 | MM14475 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.01e-03 | 10 | 68 | 2 | MM15156 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 9854018 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.04e-07 | 4 | 104 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.59e-07 | 5 | 104 | 3 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 4.07e-07 | 94 | 104 | 6 | 21542922 | |
| Pubmed | TRAF5 TRPC4AP HIVEP1 TRPC6 RAD9B MTRF1 TLE1 EFR3B KDM6A LRRD1 HYDIN | 6.88e-06 | 686 | 104 | 11 | 29987050 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29325037 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 27881772 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 34572527 | ||
| Pubmed | Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I. | 8.86e-06 | 2 | 104 | 2 | 21796158 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23912277 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22271578 | ||
| Pubmed | Reduced granulation tissue and wound strength in the absence of α11β1 integrin. | 8.86e-06 | 2 | 104 | 2 | 25634355 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 8.86e-06 | 2 | 104 | 2 | 11672541 | |
| Pubmed | 1.68e-05 | 268 | 104 | 7 | 33640491 | ||
| Pubmed | 2.05e-05 | 18 | 104 | 3 | 18664271 | ||
| Pubmed | Mechanisms of accurate translesion synthesis by human DNA polymerase eta. | 2.65e-05 | 3 | 104 | 2 | 10856253 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10516026 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 29187535 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18990704 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9971820 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 8808280 | ||
| Pubmed | Dlg5 interacts with the TGF-β receptor and promotes its degradation. | 2.65e-05 | 3 | 104 | 2 | 23624079 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19137586 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 36099033 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25673771 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11518510 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9874198 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 8645603 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 15768032 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22210772 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9334241 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 7983737 | ||
| Pubmed | PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. | 5.29e-05 | 4 | 104 | 2 | 9887105 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 29809150 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 7.21e-05 | 27 | 104 | 3 | 31541017 | |
| Pubmed | 8.06e-05 | 28 | 104 | 3 | 18617019 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 1303260 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 8.80e-05 | 5 | 104 | 2 | 11401426 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 24449818 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 8365415 | ||
| Pubmed | Citrullination of collagen II affects integrin-mediated cell adhesion in a receptor-specific manner. | 8.80e-05 | 5 | 104 | 2 | 24823363 | |
| Pubmed | 1.30e-04 | 638 | 104 | 9 | 31182584 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 8573724 | ||
| Pubmed | Interaction of hREV1 with three human Y-family DNA polymerases. | 1.32e-04 | 6 | 104 | 2 | 15189446 | |
| Pubmed | SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. | 1.32e-04 | 6 | 104 | 2 | 33514561 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 12736724 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 11672528 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPC4AP CACNA2D2 SLC38A9 ATXN7L1 ZNF875 TMPRSS6 CAPZA1 INTS3 ITPK1 PLEKHH1 YEATS2 NUP210 KDM6A ZMAT1 | 1.42e-04 | 1489 | 104 | 14 | 28611215 |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 1.59e-04 | 35 | 104 | 3 | 26091241 | |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 1.84e-04 | 7 | 104 | 2 | 24024827 | |
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 21655271 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 12093747 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 15183724 | ||
| Pubmed | 1.95e-04 | 529 | 104 | 8 | 14621295 | ||
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 16002402 | ||
| Pubmed | Genetic, morphometric, and behavioral factors linked to the midsagittal area of the corpus callosum. | 2.45e-04 | 8 | 104 | 2 | 22666227 | |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 2.45e-04 | 8 | 104 | 2 | 20735826 | |
| Pubmed | 2.86e-04 | 105 | 104 | 4 | 22493164 | ||
| Pubmed | 2.86e-04 | 105 | 104 | 4 | 9628581 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.70e-04 | 582 | 104 | 8 | 20467437 | |
| Pubmed | Genome-wide association study of co-occurring anxiety in major depression. | 3.92e-04 | 10 | 104 | 2 | 24047446 | |
| Pubmed | The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons. | 3.92e-04 | 10 | 104 | 2 | 29779948 | |
| Pubmed | 3.92e-04 | 10 | 104 | 2 | 30571765 | ||
| Pubmed | 3.92e-04 | 10 | 104 | 2 | 38016975 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 3.92e-04 | 10 | 104 | 2 | 23746844 | |
| Pubmed | 4.09e-04 | 591 | 104 | 8 | 15231748 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA7A VWA8 NLRX1 GEMIN5 ATG2A REV3L MED13L FHIP1B TOP3B TNPO3 MED13 | 4.78e-04 | 1105 | 104 | 11 | 35748872 |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 4.79e-04 | 11 | 104 | 2 | 15499562 | |
| Pubmed | The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1. | 4.79e-04 | 11 | 104 | 2 | 28536267 | |
| Pubmed | 4.83e-04 | 606 | 104 | 8 | 36538041 | ||
| Pubmed | 5.16e-04 | 52 | 104 | 3 | 9455477 | ||
| Pubmed | 5.35e-04 | 469 | 104 | 7 | 27634302 | ||
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 28700933 | ||
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 5.73e-04 | 12 | 104 | 2 | 10090148 | |
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 19693543 | ||
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 14557543 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 5.73e-04 | 12 | 104 | 2 | 11266540 | |
| Pubmed | 6.76e-04 | 13 | 104 | 2 | 10520995 | ||
| Pubmed | 6.76e-04 | 13 | 104 | 2 | 27570068 | ||
| Pubmed | Multiple loci influencing hippocampal degeneration identified by genome scan. | 6.76e-04 | 13 | 104 | 2 | 22745009 | |
| Pubmed | 6.76e-04 | 13 | 104 | 2 | 22735158 | ||
| Pubmed | 7.87e-04 | 14 | 104 | 2 | 17202186 | ||
| Pubmed | 8.17e-04 | 657 | 104 | 8 | 36180527 | ||
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 8.64e-04 | 62 | 104 | 3 | 16641997 | |
| Pubmed | 9.07e-04 | 15 | 104 | 2 | 9291577 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 9.07e-04 | 15 | 104 | 2 | 31285543 | |
| Pubmed | 9.07e-04 | 15 | 104 | 2 | 23506890 | ||
| Pubmed | TRIM25 COPB2 WRNIP1 GEMIN5 MED13L RIF1 TLE1 UHRF2 KDM6A MED13 | 9.35e-04 | 1014 | 104 | 10 | 32416067 | |
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 1.03e-03 | 16 | 104 | 2 | 12904471 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.17e-03 | 536 | 104 | 7 | 15840001 | |
| Pubmed | Shox2 function couples neural, muscular and skeletal development in the proximal forelimb. | 1.17e-03 | 17 | 104 | 2 | 21156168 | |
| Pubmed | 1.19e-03 | 538 | 104 | 7 | 10512203 | ||
| Pubmed | 1.28e-03 | 71 | 104 | 3 | 33541421 | ||
| Pubmed | Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. | 1.31e-03 | 18 | 104 | 2 | 19686679 | |
| Pubmed | 1.31e-03 | 18 | 104 | 2 | 33658226 | ||
| Pubmed | Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. | 1.31e-03 | 18 | 104 | 2 | 23575864 | |
| Pubmed | 1.31e-03 | 18 | 104 | 2 | 23669352 | ||
| Pubmed | 1.31e-03 | 18 | 104 | 2 | 11731482 | ||
| Pubmed | 1.38e-03 | 272 | 104 | 5 | 31010829 | ||
| Pubmed | 1.43e-03 | 407 | 104 | 6 | 12693553 | ||
| GeneFamily | CD molecules|Integrin alpha subunits | 4.54e-05 | 18 | 71 | 3 | 1160 | |
| GeneFamily | Cyclins|Mediator complex | 2.91e-04 | 33 | 71 | 3 | 1061 | |
| GeneFamily | DNA polymerases | 3.65e-03 | 23 | 71 | 2 | 535 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.65e-03 | 23 | 71 | 2 | 1288 | |
| GeneFamily | WD repeat domain containing | 3.68e-03 | 262 | 71 | 5 | 362 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 2.57e-05 | 230 | 98 | 7 | M11563 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.02e-05 | 180 | 98 | 6 | M8239 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 7.88e-05 | 189 | 98 | 6 | M8275 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 7.88e-05 | 189 | 98 | 6 | M45678 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 SLC38A9 ATXN7L1 GLRX2 ITGA2 ITGA9 NXT2 TGFBR2 MED12L KDM6A MED13 MBNL3 | 8.25e-05 | 854 | 98 | 12 | M1533 |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | 8.84e-05 | 378 | 98 | 8 | M34022 | |
| Coexpression | HAY_BONE_MARROW_CD34_POS_MKP | 9.83e-05 | 64 | 98 | 4 | M39187 | |
| Coexpression | GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP | 1.02e-04 | 198 | 98 | 6 | M3249 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 1.05e-04 | 199 | 98 | 6 | M9885 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP | 1.08e-04 | 200 | 98 | 6 | M9591 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN | 1.08e-04 | 200 | 98 | 6 | M9887 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 SLC38A9 ATXN7L1 GLRX2 ITGA2 ITGA9 NXT2 TGFBR2 MED12L KDM6A MED13 MBNL3 | 1.19e-04 | 888 | 98 | 12 | MM1018 |
| Coexpression | LU_EZH2_TARGETS_DN | 1.30e-04 | 400 | 98 | 8 | M2140 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.55e-07 | 183 | 97 | 7 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.05e-06 | 171 | 97 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-06 | 178 | 97 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 195 | 97 | 6 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.50e-06 | 196 | 97 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.91e-06 | 199 | 97 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 5.05e-06 | 200 | 97 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-05 | 141 | 97 | 5 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 143 | 97 | 5 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.13e-05 | 153 | 97 | 5 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-05 | 153 | 97 | 5 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-05 | 157 | 97 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-05 | 161 | 97 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 161 | 97 | 5 | c54010d88f1ecb6e0235bb66084876a4d5bf1ecd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 167 | 97 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 168 | 97 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-05 | 169 | 97 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-05 | 171 | 97 | 5 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.95e-05 | 174 | 97 | 5 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 175 | 97 | 5 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 175 | 97 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 4.52e-05 | 179 | 97 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 183 | 97 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.02e-05 | 183 | 97 | 5 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.15e-05 | 184 | 97 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.42e-05 | 186 | 97 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.56e-05 | 187 | 97 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 187 | 97 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 5.56e-05 | 187 | 97 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 188 | 97 | 5 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-05 | 188 | 97 | 5 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-05 | 188 | 97 | 5 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-05 | 188 | 97 | 5 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-05 | 189 | 97 | 5 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 189 | 97 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 5.85e-05 | 189 | 97 | 5 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 5.99e-05 | 190 | 97 | 5 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 190 | 97 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.30e-05 | 192 | 97 | 5 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 192 | 97 | 5 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 192 | 97 | 5 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.30e-05 | 192 | 97 | 5 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 192 | 97 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 192 | 97 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.46e-05 | 193 | 97 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.46e-05 | 193 | 97 | 5 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 194 | 97 | 5 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 6.78e-05 | 195 | 97 | 5 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.11e-05 | 197 | 97 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.28e-05 | 198 | 97 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.46e-05 | 199 | 97 | 5 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 995d710d7302272e7951a5a5d766d1039089ee2b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_3|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 55a1df656545ff078b727d55e4d65d61ddb5c41f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 114 | 97 | 4 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 114 | 97 | 4 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 115 | 97 | 4 | 18b962a49aaf0257ef1b4947c19917fcc6fe5863 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 127 | 97 | 4 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.71e-04 | 127 | 97 | 4 | 5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.04e-04 | 133 | 97 | 4 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-04 | 136 | 97 | 4 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.23e-04 | 136 | 97 | 4 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-04 | 150 | 97 | 4 | 580ed7733857402345f43ca2623f72cdd1edf22c | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-04 | 152 | 97 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.48e-04 | 153 | 97 | 4 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.57e-04 | 154 | 97 | 4 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 154 | 97 | 4 | d2aa24c593a1c0c6f186b74a18438b64b4e59701 | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-04 | 154 | 97 | 4 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-04 | 157 | 97 | 4 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-04 | 157 | 97 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-04 | 157 | 97 | 4 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 159 | 97 | 4 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-04 | 161 | 97 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.43e-04 | 163 | 97 | 4 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.43e-04 | 163 | 97 | 4 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-04 | 163 | 97 | 4 | 2dbdcbc4c187aad3db837d191cc78662a75dd0b5 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.43e-04 | 163 | 97 | 4 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-04 | 164 | 97 | 4 | 30c3c25b05a403a509b2e755c2f0878fecb10a02 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 4.63e-04 | 165 | 97 | 4 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.63e-04 | 165 | 97 | 4 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 165 | 97 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 165 | 97 | 4 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 4.63e-04 | 165 | 97 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 165 | 97 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 4.85e-04 | 167 | 97 | 4 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 97 | 4 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| Drug | daunorubicin HCl; Down 200; 1uM; PC3; HT_HG-U133A | 1.74e-06 | 187 | 100 | 8 | 7511_DN | |
| Drug | InBr3 | 2.84e-06 | 7 | 100 | 3 | CID000026046 | |
| Disease | Clumsiness - motor delay | 1.05e-05 | 2 | 96 | 2 | C0520947 | |
| Disease | Motor delay | 3.14e-05 | 3 | 96 | 2 | C1854301 | |
| Disease | Delayed speech and language development | 1.04e-04 | 5 | 96 | 2 | C0454644 | |
| Disease | focal segmental glomerulosclerosis (implicated_via_orthology) | 2.18e-04 | 7 | 96 | 2 | DOID:1312 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 7.00e-04 | 215 | 96 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | sphingosine 1-phosphate measurement | 1.55e-03 | 18 | 96 | 2 | EFO_0800185 | |
| Disease | nucleotide measurement | 1.76e-03 | 73 | 96 | 3 | EFO_0010513 | |
| Disease | Colorectal Carcinoma | 2.08e-03 | 702 | 96 | 8 | C0009402 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.32e-03 | 22 | 96 | 2 | C3711387 | |
| Disease | age at menopause | 3.11e-03 | 302 | 96 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHIQTPEDFFCQQLQ | 501 | Q9BXT4 | |
| QAIAVHSQDITIPQC | 1576 | Q14031 | |
| AQPVSCFTHLVQANV | 336 | Q9NY47 | |
| QTIQHNPNGRFVVVC | 356 | P35606 | |
| QQTIIACIESHQFQP | 151 | P52907 | |
| VSPQTVQTNHTVVCL | 196 | Q13304 | |
| LEQEHNNLVNVPLCV | 3161 | P11532 | |
| QPLFELRCSNNVVHV | 1206 | Q2TAZ0 | |
| NQVVKPQVFQSHCER | 106 | Q9ULK2 | |
| INQPQLTKFCNNHVS | 41 | Q9Y2Q0 | |
| TPILQALQHVQASCD | 946 | Q68E01 | |
| TCILPNVEAVSNIHN | 116 | Q96SN7 | |
| THNICFQESQPLQVI | 131 | Q6WBX8 | |
| QALHPETLISCQSQF | 1601 | Q8TEM1 | |
| EQLQQQHVSCQVFPE | 16 | Q9Y6H3 | |
| PACSQQQVIQHNTIT | 466 | Q02930 | |
| NLIQPINHTTLQCLA | 576 | Q96JP0 | |
| FCNAVIQVAHPLVQK | 306 | Q8N612 | |
| SNQFIHFPIELCQLQ | 611 | A4D1F6 | |
| IQPPCVVQNFINHNA | 181 | Q13572 | |
| LVSVTLCNQHIENSP | 561 | Q2Q1W2 | |
| LCNQHIENSPFKVVV | 566 | Q2Q1W2 | |
| HSCLILNPDQTAQVF | 891 | Q86YW9 | |
| NVCTSVEIAQHQPIY | 176 | Q71F56 | |
| QDPQEVTYAQLNHCV | 296 | P43628 | |
| LHQFCTNPNNPVTVI | 956 | O15550 | |
| SNCSHQNPFLVILVT | 71 | O75752 | |
| CHNVLNCQVLITVPE | 831 | Q5H9U9 | |
| QQFEEPCHVNSSQLI | 1321 | O43157 | |
| HNVINNIFCDLPLVI | 171 | Q8NH43 | |
| NLISQLTTVPAFCQH | 601 | Q9Y2G0 | |
| QQCDTITILAQYNPH | 1416 | Q8TDM6 | |
| VQHCTQCQVLHLPTQ | 621 | P63132 | |
| NCNSVPHVSKERIQQ | 561 | Q8NG31 | |
| TPINIQNIFLDHCVQ | 66 | Q05C16 | |
| PQLNHSNSDVVSINC | 1056 | Q9UKX5 | |
| HDQCQITTLRLSNNP | 776 | Q86UT6 | |
| VNQAQSCPEHIIYIQ | 731 | P17301 | |
| TQQLPEVLQCQPQHY | 16 | Q8WVV4 | |
| VQHCTQCQILHLPTQ | 621 | P63135 | |
| VQHCTQCQVLHLPTQ | 621 | Q9BXR3 | |
| LIQCPRVQFQINSHA | 46 | Q15390 | |
| VQHCTQCQVLDLPTQ | 621 | Q9QC07 | |
| CHFQPINITLQVYNT | 801 | Q13797 | |
| VNHCQNTVLSVPNLV | 541 | Q9C0G6 | |
| QATPECFAHLTQLLQ | 276 | Q969S8 | |
| CLVETIQLSNHLQVP | 1716 | Q4G0P3 | |
| FCPHLQNSTQLEQVN | 576 | O14638 | |
| PVNQIQETISDNCVV | 56 | Q9NS18 | |
| TVFHCQQALTNLQLP | 286 | Q9NUK0 | |
| VQSICNALEVPHIQL | 121 | Q13003 | |
| NQQTVLLPESCQHLI | 241 | Q9UNA4 | |
| TQNEQCPQVSFHQAI | 406 | Q92681 | |
| CIEPTNIVNVNHVIQ | 41 | Q8NBW4 | |
| NCIEHVQPTSAFIQQ | 241 | P10243 | |
| QTLSIQQCLPHRKNF | 46 | Q86WN2 | |
| DTPHLQVLLFQNCNL | 276 | Q8WUT4 | |
| NIQINHTVLIATGCF | 191 | P34982 | |
| LDCQPVHEQATQSQT | 76 | Q9NPJ8 | |
| QTSLLTNLHCFQPDV | 36 | Q8TB92 | |
| FNPNNHQSEQTLCVV | 451 | Q9H0F5 | |
| VPEIQDQVSCQAHVN | 666 | Q7Z6B7 | |
| IHVQTLTQENVSCLN | 676 | Q8TEL6 | |
| QLLQIQPAHFSQCSN | 136 | Q8TF66 | |
| NFEQVCVPLIQSTIS | 356 | Q5UIP0 | |
| SHCNVTPLSFQVQAQ | 236 | O60902 | |
| VLNCQQATQIVPHQG | 226 | Q6UWI4 | |
| CANNINHNTELLPIE | 231 | P37173 | |
| SQELSFLHPCTQQIL | 821 | Q6ZUB1 | |
| HVNQELLQISPCITE | 1016 | Q8N3P4 | |
| LCQFNPTQVIETLQV | 1036 | Q8N3P4 | |
| QHFQTVSPEVKNICI | 296 | Q9GZT4 | |
| DSNVCTSVEINQHQP | 171 | Q9UHV7 | |
| YQTLEQCLQHIPVNE | 86 | O75570 | |
| CFVTQLQHNEIIPSE | 101 | Q86UD1 | |
| QDHLQQCLFQPVQCS | 126 | O00463 | |
| FTQLQTLILPQHVNC | 116 | Q6UW56 | |
| SNCQHFVSQVDTQVP | 216 | Q969H4 | |
| QLTPQQQHLIREDCQ | 691 | Q96PU4 | |
| DASIPVHINNICQRN | 511 | O95985 | |
| NHSCCPNLLVQNVFV | 651 | Q96T68 | |
| NTICAQVIPFLSQEH | 86 | Q04724 | |
| TPNFLHCKDSQQQIV | 1416 | O60673 | |
| TTNNCHNNETVILTP | 176 | Q7Z2H8 | |
| EVCQVSAQQPVQTEL | 341 | O43295 | |
| PQLHKNTVLCNVVEQ | 61 | Q14258 | |
| IQHQLSIQRIACSFP | 91 | Q8IV35 | |
| QNHSRIVFNLCPLQT | 331 | Q8TEQ6 | |
| VQHCTQCQVLHLPTQ | 621 | P10266 | |
| IQQNLRTHCIDVYPQ | 211 | Q8IYM1 | |
| VQHCTQCQVLHLPTQ | 621 | P63133 | |
| VQHCTQCQVLHLPTQ | 621 | Q9UQG0 | |
| HQSPNCILFIENLTA | 591 | O75326 | |
| QTALQVCLVHPELQS | 881 | Q9ULM0 | |
| FPVILSIENHCSIQQ | 386 | Q4KWH8 | |
| VENGQTHPCQKVIQE | 626 | Q9Y5L0 | |
| FLSQLHQVQCPVCQQ | 11 | Q96S55 | |
| CPLIFSSQQALSQHV | 116 | P10072 | |
| KFVAHPNCQQQLLSI | 376 | Q9Y210 | |
| CTNFQKNNPVHTLTE | 351 | Q6P3X3 | |
| HENEQNTLYVVTCNP | 1121 | A3KMH1 | |
| SILCQLNHPCVIQFV | 511 | Q59H18 | |
| GICAQIIPFLTQEHQ | 86 | Q04725 | |
| NQPICQTNHSVVPIS | 1666 | P15822 | |
| EITVSNIHQAICNIP | 1391 | Q9ULM3 | |
| SVQPVVFQACEVNLT | 326 | Q8IU80 | |
| YSISQVVENQLPHCL | 456 | Q5H9K5 |